The second-generation Dectin-1-CAR previously proposed by our group demonstrated specific recognition of β-glucans, elicited antifungal activity against AF in vitro, and conferred modest in vivo protection in immunocompromised mice with IA (14). Here, CLEC7A is linked to atrial fibrillation.